Truist Financial Corp Teva Pharmaceutical Industries LTD Transaction History

Truist Financial Corp

$62.9 Billion
Q3 2024

A detailed history of Truist Financial Corp transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Truist Financial Corp holds 1,388,822 shares of TEVA stock, worth $23.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,388,822

Previous 3,885,251 64.25%

Holding current value

$23.1 Million

Previous $63.1 Million 60.36%

% of portfolio

0.04%

Previous 0.1%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$15.81 - $18.96 $39.5 Million - $47.3 Million	-2,496,429 Reduced 64.25%	1,388,822 $25 Million
Q2 2024 Aug 20, 2024	BUY	$12.78 - $17.4 $3.25 Million - $4.43 Million	254,483 Added 7.01%	3,885,251 $63.1 Million
Q1 2024 May 10, 2024	BUY	$10.67 - $14.43 $37.3 Million - $50.5 Million	3,496,746 Added 2609.08%	3,630,768 $51.2 Million
Q4 2023 Feb 02, 2024	BUY	$8.12 - $10.63 $14,339 - $18,772	1,766 Added 1.34%	134,022 $1.4 Million
Q3 2023 Nov 14, 2023	SELL	$7.48 - $10.7 $313,374 - $448,276	-41,895 Reduced 24.06%	132,256 $1.35 Million
Q2 2023 Aug 01, 2023	BUY	$7.2 - $9.47 $264,326 - $347,662	36,712 Added 26.71%	174,151 $1.31 Million
Q1 2023 May 05, 2023	SELL	$8.36 - $11.37 $114,506 - $155,734	-13,697 Reduced 9.06%	137,439 $1.22 Million
Q4 2022 Feb 17, 2023	SELL	$7.95 - $9.48 $65,388 - $77,973	-8,225 Reduced 5.16%	151,136 $1.38 Million
Q3 2022 Oct 26, 2022	BUY	$6.86 - $11.95 $174,737 - $304,390	25,472 Added 19.02%	159,361 $1.29 Million
Q2 2022 Jul 22, 2022	SELL	$7.38 - $10.4 $222,521 - $313,580	-30,152 Reduced 18.38%	133,889 $1.01 Million
Q1 2022 Apr 22, 2022	SELL	$7.33 - $9.39 $49,997 - $64,049	-6,821 Reduced 3.99%	164,041 $1.54 Million
Q4 2021 Feb 14, 2022	BUY	$7.9 - $10.19 $276,539 - $356,700	35,005 Added 25.77%	170,862 $1.37 Million
Q3 2021 Nov 05, 2021	BUY	$8.38 - $10.18 $197,483 - $239,901	23,566 Added 20.99%	135,857 $1.32 Million
Q2 2021 Aug 16, 2021	SELL	$9.9 - $11.56 $22,007 - $25,697	-2,223 Reduced 1.94%	112,291 $1.11 Million
Q1 2021 May 17, 2021	BUY	$10.34 - $12.81 $752,421 - $932,158	72,768 Added 174.31%	114,514 $1.32 Million
Q4 2020 Feb 18, 2021	SELL	$8.61 - $11.04 $591,205 - $758,061	-68,665 Reduced 62.19%	41,746 $402,000
Q3 2020 Nov 13, 2020	BUY	$8.57 - $12.69 $9,598 - $14,212	1,120 Added 1.02%	110,411 $995,000
Q2 2020 Aug 14, 2020	SELL	$8.12 - $13.12 $117,066 - $189,151	-14,417 Reduced 11.65%	109,291 $1.35 Million
Q1 2020 May 15, 2020	SELL	$6.69 - $13.45 $32,867 - $66,079	-4,913 Reduced 3.82%	123,708 $1.11 Million
Q4 2019 Feb 14, 2020	BUY	$6.53 - $10.72 $839,895 - $1.38 Million	128,621 New	128,621 $1.26 Million

Others Institutions Holding TEVA

# of Institutions

626

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.5B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Teva Pharmaceutical Industries LTD Transaction History